Joe M. O’Sullivan

24.5k total citations · 4 hit papers
258 papers, 8.3k citations indexed

About

Joe M. O’Sullivan is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Joe M. O’Sullivan has authored 258 papers receiving a total of 8.3k indexed citations (citations by other indexed papers that have themselves been cited), including 175 papers in Pulmonary and Respiratory Medicine, 126 papers in Radiology, Nuclear Medicine and Imaging and 67 papers in Oncology. Recurrent topics in Joe M. O’Sullivan's work include Prostate Cancer Treatment and Research (108 papers), Radiopharmaceutical Chemistry and Applications (78 papers) and Advanced Radiotherapy Techniques (57 papers). Joe M. O’Sullivan is often cited by papers focused on Prostate Cancer Treatment and Research (108 papers), Radiopharmaceutical Chemistry and Applications (78 papers) and Advanced Radiotherapy Techniques (57 papers). Joe M. O’Sullivan collaborates with scholars based in United Kingdom, United States and Ireland. Joe M. O’Sullivan's co-authors include Kevin M. Prise, Suneil Jain, D G Hirst, Alan R. Hounsell, Karl T. Butterworth, Stephen J. McMahon, Sten Nilsson, Conor K. McGarry, Oliver Sartor and Jonathan A. Coulter and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Nature reviews. Cancer.

In The Last Decade

Joe M. O’Sullivan

250 papers receiving 8.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gold nanoparticles as novel agents for cancer therapy

2012 794 citations Suneil Jain, Joe M. O’Sullivan et al. profile →
Radiation-induced bystander signalling in cancer therapy

2009 644 citations Kevin M. Prise, Joe M. O’Sullivan profile →
Cell-Specific Radiosensitization by Gold Nanoparticles at Megavoltage Radiation Energies

2010 376 citations Suneil Jain, Alan R. Hounsell et al. International Journal of Radiation Oncology*Biology*Physics profile →
Efficacy and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and symptomatic bone metastases, with or without previous docetaxel use: a prespecified subgroup analysis from the randomised, double-blind, phase 3 ALSYMPCA trial

2014 290 citations Oliver Sartor, Joe M. O’Sullivan et al. profile →

Peers

Countries citing papers authored by Joe M. O’Sullivan

Since Specialization

Citations

This map shows the geographic impact of Joe M. O’Sullivan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joe M. O’Sullivan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joe M. O’Sullivan more than expected).

Fields of papers citing papers by Joe M. O’Sullivan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joe M. O’Sullivan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joe M. O’Sullivan. The network helps show where Joe M. O’Sullivan may publish in the future.

Co-authorship network of co-authors of Joe M. O’Sullivan

This figure shows the co-authorship network connecting the top 25 collaborators of Joe M. O’Sullivan. A scholar is included among the top collaborators of Joe M. O’Sullivan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joe M. O’Sullivan. Joe M. O’Sullivan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comparison of Adult and Child Endotracheal Administration of Epinephrine in a Normovolemic Cardiac Arrest Model 2024 ·Don Johnson, Joe M. O’Sullivan, (unknown), (unknown), (unknown), Julie G. Hensler	1
2	Feasibility of home-based exercise training during adjuvant treatment for metastatic castrate-resistant prostate cancer patients treated with an androgen receptor pathway inhibitor (EXACT) 2023 ·Supportive Care in Cancer ·Malcolm Brown, Marie Murphy, Helen McAneney, (unknown), (unknown), Aidan Cole, Joe M. O’Sullivan, Suneil Jain, Gillian Prue	3
3	Toxicity and Efficacy of Concurrent Androgen Deprivation Therapy, Pelvic Radiotherapy, and Radium-223 in Patients with De Novo Metastatic Hormone-Sensitive Prostate Cancer 2021 ·Clinical Cancer Research ·(unknown), Suneil Jain, Aidan Cole, Glaxy Grey, D. Mitchell, Kevin M. Prise, Alan R. Hounsell, Conor K. McGarry, (unknown), Joe M. O’Sullivan	7
4	Hormone therapy use and the risk of acute kidney injury in patients with prostate cancer: a population-based cohort study 2021 ·Prostate Cancer and Prostatic Diseases ·Chris R. Cardwell, Joe M. O’Sullivan, Suneil Jain, Blánaid Hicks, (unknown), Úna C. McMenamin	6
5	Targeted Alpha Therapy: Current Clinical Applications 2020 ·Cancer Biotherapy and Radiopharmaceuticals ·(unknown), Joe M. O’Sullivan, Stephen J. McMahon, Kevin M. Prise	73
6	Randomized Interventional Study on Prediction of Preeclampsia/Eclampsia in Women With Suspected Preeclampsia 2019 ·Hypertension ·Ana Sofia Cerdeira, Joe M. O’Sullivan, Eric O. Ohuma, Deborah J. Harrington, (unknown), Rebecca Black, Lucy Mackillop, Lawrence Impey, Catherine Greenwood, Tim James, (unknown), Aris T. Papageorghiou, Marian Knight, Manu Vatish	98
7	Investigating the psychological impact of active surveillance or active treatment in newly diagnosed favorable‐risk prostate cancer patients: A 9‐month longitudinal study 2019 ·Psycho-Oncology ·(unknown), Sam Porter, Joe M. O’Sullivan, Martin Dempster, Gillian Prue	14
8	Computed Tomography-based Radiomics for Risk Stratification in Prostate Cancer 2019 ·International Journal of Radiation OncologyBiologyPhysics ·Sarah Osman, Ralph T. H. Leijenaar, Aidan Cole, C. Lyons, Alan R. Hounsell, Kevin M. Prise, Joe M. O’Sullivan, Philippe Lambin, Conor K. McGarry, Suneil Jain	39
9	N‐linked glycan truncation causes enhanced clearance of plasma‐derived von Willebrand factor 2016 ·Journal of Thrombosis and Haemostasis ·Joe M. O’Sullivan, Sonia Águila, (unknown), Soracha E. Ward, Orla Rawley, Padraic G. Fallon, Teresa M. Brophy, Roger J. S. Preston, Lauren Brady, Orla Sheils, Alain Chion, James S. O’Donnell	30
10	An exploration of men’s experiences of undergoing active surveillance for favourable-risk prostate cancer: A mixed methods study protocol 2016 ·BMC Cancer ·(unknown), Joe M. O’Sullivan, Sam Porter, Lionne D. F. Venderbos, Gillian Prue	4
11	Active surveillance for favorable‐risk prostate cancer: Is there a greater psychological impact than previously thought? A systematic, mixed studies literature review 2016 ·Psycho-Oncology ·(unknown), Sam Porter, Joe M. O’Sullivan, Olinda Santin, Gillian Prue	22
12	Efficacy and Safety of Radium-223 Dichloride in Symptomatic Castration-resistant Prostate Cancer Patients With or Without Baseline Opioid Use From the Phase 3 ALSYMPCA Trial 2016 ·European Urology ·Christopher Parker, Steven E. Finkelstein, Jeff M. Michalski, Joe M. O’Sullivan, Øyvind S. Bruland, Nicholas J. Vogelzang, Robert E. Coleman, Sten Nilsson, Oliver Sartor, Rui Li, Monica Seger, David Bottomley	51
13	External beam radiation therapy (EBRT) use and safety with radium-223 dichloride (Ra-223) in patients (pts) with castration-resistant prostate cancer (CRPC) and symptomatic bone metastases (mets) from the ALSYMPCA trial 2015 ·Annals of Oncology ·(unknown), Claudio Rossetti, Massimo Aglietta, Caterina Messina, Annibale Versari, (unknown), Joe M. O’Sullivan, Chris Parker, (unknown), (unknown), (unknown)	3
14	Time and Cell Type Dependency of Survival Responses in Co-cultured Tumor and Fibroblast Cells after Exposure to Modulated Radiation Fields 2015 ·Radiation Research ·Karl T. Butterworth, Stephen J. McMahon, (unknown), Gaurang Patel, Mihaela Ghita, Aidan Cole, Conor K. McGarry, Joe M. O’Sullivan, Alan R. Hounsell, Kevin M. Prise	10
15	Radium-223 dichloride for the treatment of metastatic prostate cancer 2014 ·Expert Opinion on Pharmacotherapy ·(unknown), Joe M. O’Sullivan	3
16	Hematologic safety of radium-223 dichloride (Ra-223) in the phase 3 ALSYMPCA trial in castration-resistant prostate cancer (CRPC) patients with bone metastases : baseline prognostic factor subgroup analysis 2013 ·European Journal of Cancer ·Joe M. O’Sullivan, Dag Clement Johannessen, Anders Widmark, Isabel Syndikus, (unknown), Marcos F. Dall’Oglio, I.K. Haugen, A.J. Cross, J. Garcia‐Vargas, N. Vogelzang	3
17	Elevation of c-FLIP in Castrate-Resistant Prostate Cancer Antagonizes Therapeutic Response to Androgen Receptor–Targeted Therapy 2012 ·Clinical Cancer Research ·(unknown), Pamela Maxwell, Roberta Mazzucchelli, Rodolfo Montironi, Marina Scarpelli, Manuel Salto‐Tellez, Joe M. O’Sullivan, Daniel B. Longley, David Waugh	51
18	Reverse arterial wall shear stress causes nitric oxide-dependent vasodilatation in the anaesthetised dog 2002 ·Pflügers Archiv - European Journal of Physiology ·F. Markos, (unknown), Mike Fitzpatrick, Joe M. O’Sullivan, Harold D. Snow	10
19	Quantitative analysis of bone scans to determine if the dose to individual metastases from high activity Re186HEDP therapy depends upon the number of metastases 2001 ·Radiology ·V. R. McCready, Joe M. O’Sullivan, David P. Dearnaley, J. Treleaven	1
20	HER-2 expression and response to tamoxifen in estrogen receptor-positive breast cancer: a Southwest Oncology Group Study. 1998 ·PubMed ·Richard Elledge, (unknown), Daniel R. Ciocca, R Pugh, D. Craig Allred, Gary M. Clark, (unknown), Peter M. Ravdin, Joe M. O’Sullivan, Silvana Martino, C. Kent Osborne	203

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact